Wilmington Oct 5, 2019 (Thomson StreetEvents) — Edited Transcript of Charles River Laboratories International Inc earnings conference call or presentation Wednesday, July 31, 2019 at 12:30:00pm GMT Charles River Laboratories International, Inc. – Corporate Executive VP & CFO * James C. Foster Charles River Laboratories International, Inc. – Chairman, CEO & President Charles River Laboratories International, Inc. – Corporate VP of IR UBS Investment Bank, Research Division – Senior Equity Research Analyst of Healthcare Life Sciences Robert W. Baird & Co. Incorporated, Research Division – Senior Research Analyst William Blair & Company L.L.C., Research Division – Partner & Healthcare Services Analyst Evercore ISI Institutional Equities, Research Division – Senior MD, Head of Healthcare Services & Technology and Fundamental Research Analyst * Stephen C. Baxter * Tycho W. Peterson Ladies and gentlemen, thank you for standing by, and welcome to the Charles River Laboratories Second Quarter 2019 Earnings Conference Call. (Operator Instructions) And as a reminder, this conference is being recorded. I would now like to turn the conference over to our host, Todd Spencer, Corporate Vice President of Investor Relations. Please go ahead. Todd Spencer, Charles River Laboratories International, Inc. – Corporate VP of IR  Thank you. Good morning,… Read full this story
- Quantum Physics - The Discovery That Scientifically Demolished Materialism
- Centennial Salutes to the Birth, Growth and Development of Richard Wright As a Writer
- Rise In Nation's Inflation Rate - A Symptom For Software Project Failure
Edited Transcript of CRL earnings conference call or presentation 31-Jul-19 12:30pm GMT have 221 words, post on finance.yahoo.com at October 4, 2019. This is cached page on wBird. If you want remove this page, please contact us.